These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26677053)

  • 21. Assessment of neurocognitive function in association with WHO grades in gliomas.
    Yamawaki R; Nankaku M; Umaba C; Ueda M; Liang N; Mineharu Y; Yamao Y; Ikeguchi R; Matsuda S; Miyamoto S; Arakawa Y
    Clin Neurol Neurosurg; 2021 Sep; 208():106824. PubMed ID: 34329808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study.
    Piil K; Jakobsen J; Christensen KB; Juhler M; Jarden M
    J Neurooncol; 2015 Sep; 124(2):185-95. PubMed ID: 26026860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic-Affective, But Not Cognitive-Depressive Symptoms are Associated With Reduced Health-Related Quality of Life in Patients With Congestive Heart Failure.
    Patron E; Messerotti Benvenuti S; Lopriore V; Aratari J; Palomba D
    Psychosomatics; 2017; 58(3):281-291. PubMed ID: 28189288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
    Geens W; Vanlaer N; Nijland L; Van Laere S; Schwarze JK; Bruneau M; Neyns B; Rogiers A; Duerinck J
    J Neurooncol; 2024 May; 168(1):159-169. PubMed ID: 38502281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life.
    Stöckelmaier L; Renovanz M; König J; Nickel K; Hickmann AK; Mayer-Steinacker R; Nadji-Ohl M; Ganslandt O; Bullinger L; Wirtz CR; Coburger J
    World Neurosurg; 2017 Jun; 102():383-399. PubMed ID: 28288921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in stable, long-term survivors of low-grade glioma.
    Boele FW; Douw L; Reijneveld JC; Robben R; Taphoorn MJ; Aaronson NK; Heimans JJ; Klein M
    J Clin Oncol; 2015 Mar; 33(9):1023-9. PubMed ID: 25667287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verbal Learning Processes in Patients with Glioma of the Left and Right Temporal Lobes.
    Noll KR; Weinberg JS; Ziu M; Wefel JS
    Arch Clin Neuropsychol; 2016 Feb; 31(1):37-46. PubMed ID: 26537777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques.
    Racine CA; Li J; Molinaro AM; Butowski N; Berger MS
    Neurosurgery; 2015 Sep; 77(3):371-9; discussion 379. PubMed ID: 25930064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive status in patients with newly-diagnosed brain tumors in good neurological condition: The impact of tumor type, volume, and location.
    Hendrix P; Hans E; Griessenauer CJ; Simgen A; Oertel J; Karbach J
    Clin Neurol Neurosurg; 2017 May; 156():55-62. PubMed ID: 28334687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors.
    Hahn CA; Dunn RH; Logue PE; King JH; Edwards CL; Halperin EC
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):992-9. PubMed ID: 12605978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal Analysis of Depression and Anxiety Symptoms as Independent Predictors of Neurocognitive Function in Primary Brain Tumor Patients.
    Tibbs MD; Huynh-Le MP; Reyes A; Macari AC; Karunamuni R; Tringale K; Burkeen J; Marshall D; Xu R; McDonald CR; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1229-1239. PubMed ID: 32634542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients.
    Lehrner J; Kalchmayr R; Serles W; Olbrich A; Pataraia E; Aull S; Bacher J; Leutmezer F; Gröppel G; Deecke L; Baumgartner C
    Seizure; 1999 Apr; 8(2):88-92. PubMed ID: 10222299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
    Wefel JS; Zhou R; Sulman EP; Boehling NS; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Kahalley LS; Small BJ; Scheurer ME; Bondy ML; Liu Y
    J Neurooncol; 2022 Jan; 156(1):185-193. PubMed ID: 34817796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.
    Hall WA; Pugh SL; Wefel JS; Armstrong TS; Gilbert MR; Brachman DG; Werner-Wasik M; Wendland MM; Brown PD; Chao ST; Roof KS; Robins HI; Mehta MP; Curran WJ; Movsas B
    Neurosurgery; 2019 Jan; 84(1):66-76. PubMed ID: 29618054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facets and determinants of quality of life in patients with recurrent high grade glioma.
    Giovagnoli AR; Silvani A; Colombo E; Boiardi A
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):562-8. PubMed ID: 15774446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mnesic disorders caused by left temporal gliomas].
    Verlut C; Sylvestre G; Curtit E; Baron MH; Medeiros De Bustos E; Moulin T; Magnin E
    Rev Neurol (Paris); 2015 Apr; 171(4):382-9. PubMed ID: 25847397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization.
    Helmstaedter C; Sonntag-Dillender M; Hoppe C; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):696-701. PubMed ID: 15380121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study.
    Bunevicius A
    Health Qual Life Outcomes; 2017 May; 15(1):92. PubMed ID: 28472964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
    van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
    J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.